Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

That's the total value of pharmaceuticals China imported last year, up from $27 billion in 2017. Despite Beijing's drive for economic self-sufficiency, it has continued to welcome U.S. medical ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

President Donald Trump said he will most likely impose tariffs on pharmaceuticals as soon as the end of the month, along with tariffs on semiconductors, Bloomberg reported July 15. Here are four notes ...

Johnson and Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as ...

Drugmaker Swedish Orphan Biovitrum AB’s Chief Executive Officer Guido Oelkers said he doesn’t think tariff threats on the ...

President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...